Tomoyoshi Komiyama

Dr. Tomoyoshi Komiyama

Department of Clinical Pharmacology, Tokai University School of Medicine, Japan
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2009 in Gene
Verified
Journal Article
Closed access
Tomoyoshi KomiyamaTomoyoshi Komiyama
Tomoyoshi Komiyama
HKHiroyuki Kobayashi
Hiroyuki Kobayashi
YTYoshio Tateno
Yoshio Tateno
HIHidetoshi Inoko
Hidetoshi Inoko
TGTakashi Gojobori
Takashi Gojobori
KIKazuho Ikeo
Kazuho Ikeo

1 October 2003 in Gene
Verified
Journal Article
Closed access
Tomoyoshi KomiyamaTomoyoshi Komiyama
Tomoyoshi Komiyama
KIKazuho Ikeo
Kazuho Ikeo
TGTakashi Gojobori
Takashi Gojobori

1 July 2020 in EBioMedicine
Verified
Journal Article
Open access
AOAkira Oka
Akira Oka
ATAtsushi Takagi
Atsushi Takagi
EKEtsuko Komiyama
Etsuko Komiyama
NYNagisa Yoshihara
Nagisa Yoshihara
SMShuhei Mano
Shuhei Mano
SIShigaku Ikeda
Shigaku Ikeda
Alopecia areata (AA) is considered a highly heritable, T-cell-mediated autoimmune disease of the hair follicle. However, no convincing susceptibility gene has yet been pinpointed in the major histocompatibility complex (MHC), a genome region known to be associated with AA as compared to other regions. We engineered mice carrying AA risk allele identified by haplotype sequencing for the MHC region using allele-specific genome editing with the CRISPR/Cas9 system. Finally, we performed functional evaluations in the mice and AA patients with and without the risk allele. We identified a variant (rs142986308, p.Arg587Trp) in the coiled-coil alpha-helical rod protein 1 (CCHCR1) gene as the only non-synonymous variant in the AA risk haplotype. Furthermore, mice engineered to carry the risk allele displayed a hair loss phenotype. Transcriptomics further identified CCHCR1 as a novel component interacting with hair cortex keratin in hair shafts. Both, these alopecic mice and AA patients with the risk allele displayed morphologically impaired hair and comparable differential expression of hair-related genes, including hair keratin and keratin-associated proteins (KRTAPs). Our results implicate CCHCR1 with the risk allele in a previously unidentified subtype of AA based on aberrant keratinization in addition to autoimmune events. This work was supported by JSPS KAKENHI (JP16K10177) and the NIHR UCLH Biomedical Research center (BRC84/CN/SB/5984).

1 December 2008 in Gene
Verified
Journal Article
Closed access
LJLihua Jin
Lihua Jin
KKKirill Kryukov
Kirill Kryukov
JCJose C. Clemente
Jose C. Clemente
Tomoyoshi KomiyamaTomoyoshi Komiyama
Tomoyoshi Komiyama
YSYoshiyuki Suzuki
Yoshiyuki Suzuki
TGTakashi Gojobori
Takashi Gojobori

1 May 2004 in Gene
Verified
Journal Article
Closed access
Tomoyoshi KomiyamaTomoyoshi Komiyama
Tomoyoshi Komiyama
KIKazuho Ikeo
Kazuho Ikeo
TGTakashi Gojobori
Takashi Gojobori

24 April 2022 in Biology
Verified
Journal Article
Open access
PDF file
TMTsutomu Murakami
Tsutomu Murakami
Tomoyoshi KomiyamaTomoyoshi Komiyama
Tomoyoshi Komiyama
HKHiroyuki Kobayashi
Hiroyuki Kobayashi
YIYuji Ikari
Yuji Ikari
Most patients with Takotsubo Syndrome (TTS) are postmenopausal females. TTS in males is rare and gender differences have not been sufficiently investigated. Therefore, we investigated gender differences in TTS. TTS in males and females is often triggered by physical and emotional stress, respectively. Heart failure, a severe in-hospital complication, requires greater mechanical respiratory support in males. Fatal arrhythmias such as ventricular tachycardia and ventricular fibrillation and in-hospital mortality rates are higher in males. The white blood cell (WBC) count has been shown to be higher in males than in females with cardiovascular death compared with non-cardiovascular death. Therefore, the WBC count, a simple marker, may reflect severe TTS. Decreased estrogen levels, common in postmenopausal females, are a pathogenic mechanism of TTS. Females have a more significant increase in the extracellular matrix-receptor interaction than males. Moreover, the pathological findings after hematoxylin–eosin staining were different in males and females. Males had more severe complications than females in the acute phase of TTS; thus, more careful observations and interventions are likely required. From these results, it can be considered that the mechanism of the onset of TTS may be different between males and females. Therefore, it is necessary to fully understand the gender differences in order to more effectively manage TTS.